Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Magdy El-Salhy, Tarek Mazzawi, Trygve Hausken & Jan Gunnar Hatlebakk. (2022) The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms. Scandinavian Journal of Gastroenterology 57:9, pages 1036-1045.
Read now
Read now
Alassan Kouamé Mahassadi, Paulin Christian Ebela, Aboubacar Demba Bangoura & Alain Koffi Attia. (2019) The burden of irritable bowel syndrome and chronic constipation on health-related quality of life in black Africans: a comparison with healthy control subjects in Côte d’Ivoire, West Africa. Clinical and Experimental Gastroenterology 12, pages 355-365.
Read now
Read now
Beatrice Biasini, Laura Marchi, Donato Angelino, Giorgio Bedogni, Ivana Zavaroni, Carlo Pruneti, Daniela Galli, Prisco Mirandola, Marco Vitale, Alessandra Dei Cas, Riccardo C. Bonadonna, Giovanni Passeri, Marco Ventura, Daniele Del Rio & Daniela Martini. (2018) Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006. International Journal of Food Sciences and Nutrition 69:7, pages 771-804.
Read now
Read now
Articles from other publishers (41)
Ligang Liu, Anlin Wang, Hekai Shi, Heqing Tao & Milap C. Nahata. (2023) Efficacy and safety of probiotics and synbiotics for functional constipation in children: A systematic review and meta-analysis of randomized clinical trials. Clinical Nutrition 42:10, pages 1817-1826.
Crossref
Crossref
Roberto Ybañez-Julca, Ricardo Pino-Ríos, Iván Quispe-Díaz, Daniel Asunción-Alvarez, Edwin Acuña-Tarrillo, Elena Mantilla-Rodríguez, Patricia Minchan-Herrera, Marcelo Catalán, Liz Zevallos-Escobar, Edison Vásquez-Corales, Osvaldo Yáñez, Wilfredo Gutiérrez-Alvarado & Julio Benites. (2023) Antispasmodic Effect of Valeriana pilosa Root Essential Oil and Potential Mechanisms of Action: Ex Vivo and In Silico Studies. Pharmaceutics 15:8, pages 2072.
Crossref
Crossref
Joel Flores‐Arriaga, María C. Aso, Arantzazu Izagirre, Ami D. Sperber, Olafur S. Palsson, Shrikant I. Bangdiwala, Ángel Lanas, Luis Bujanda, Beatriz Lobo, Carmen Alonso‐Cotoner, Álex Sánchez‐Pla & Javier Santos. (2023)
Prevalence and description of disorders of
gut–brain
interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study
. Neurogastroenterology & Motility 35:6.
Crossref
Crossref
Agata Mulak, Tamar Freud, Marek Waluga, Shrikant I. Bangdiwala, Olafur S. Palsson & Ami D. Sperber. (2023) Sex‐ and gender‐related differences in the prevalence and burden of disorders of gut‐brain interaction in Poland. Neurogastroenterology & Motility 35:6.
Crossref
Crossref
Nikos Rikos, Chara Frantzeskaki, Maria Fragiadaki, Anna Kassotaki, Andreas Mpalaskas, Manolis Linardakis & Georgios Vasilopoulos. (2023) Investigation of the Quality of Life of Patients with Gastrointestinal Issues Treated in the Surgical Clinic of a Regional General Hospital in Greece. Clinics and Practice 13:2, pages 520-528.
Crossref
Crossref
J. BouSaba, S. Dilmaghani, A. Taylor, I. Busciglio, S. McKinzie & M. Camilleri. (2023) Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome. Gastro Hep Advances 2:5, pages 623-625.
Crossref
Crossref
Chuanli Yang, Xinshu Bai, Tianjiao Hu, Xin Xue, Xiaohu Su, Xuan Zhang, Teng Wu, Mingxia Zhang, Xiaobing Shen & Xiushan Dong. (2022) Integrated metagenomics and targeted-metabolomics analysis of the effects of phenylalanine on loperamide-induced constipation in rats. Frontiers in Microbiology 13.
Crossref
Crossref
Magdy El‐Salhy, Tarek Mazzawi, Trygve Hausken & Jan Gunnar Hatlebakk. (2022) Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. Neurogastroenterology & Motility 34:9.
Crossref
Crossref
Joelle BouSaba, Wassel Sannaa, Sanna McKinzie, Priya Vijayvargiya, Victor Chedid, Xiao Jing Wang, Jessica Atieh, Ting Zheng, Justin Brandler, Ann L. Taylor, Irene Busciglio, W. Scott Harmsen & Michael Camilleri. (2022) Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life. Clinical Gastroenterology and Hepatology 20:9, pages 2083-2090.e1.
Crossref
Crossref
Kexin Wang, Huan Liu, Jingjing Liu, Liyuan Han, Zheng Kang, Libo Liang, Shengchao Jiang, Nan Meng, Peiwen Chen, Qiao Xu, Qunhong Wu & Yanhua Hao. (2022) Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank. Frontiers in Pharmacology 13.
Crossref
Crossref
Khaled A. Jadallah, Moawiah M. Khatatbeh, Enas W. Sarsak, Aroob N. Sweidan & Bara F. Alzubi. (2022) Irritable bowel syndrome and its associated factors among Jordanian medical students: A cross-sectional study. Medicine 101:33, pages e30134.
Crossref
Crossref
Ami D. Sperber, Tamar Freud, Naim Abu‐Freha, Fahmi Shibli, Rita Brun, Shrikant I. Bangdiwala, Olafur S. Palsson & Ram Dickman. (2022) Epidemiology of disorders of Gut‐Brain interaction in Israel: Results from the Rome Foundation global epidemiology study. Neurogastroenterology & Motility 34:8.
Crossref
Crossref
Bhavesh Patel, Alessio Gizzi, Javad Hashemi, Yousif Awakeem, Hans Gregersen & Ghassan Kassab. (2022) Biomechanical constitutive modeling of the gastrointestinal tissues: A systematic review. Materials & Design 217, pages 110576.
Crossref
Crossref
Magdy El‐Salhy, Anja Bråthen Kristoffersen, Jørgen Valeur, Christina Casen, Jan Gunnar Hatlebakk, Odd Helge Gilja & Trygve Hausken. (2021) Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterology & Motility 34:1.
Crossref
Crossref
Jocelynn T. Owusu, Alice Sibelli, Rona Moss‐Morris, Miranda A.L. van Tilburg, Rona L. Levy & Megan Oser. (2021) A pilot feasibility study of an unguided, internet‐delivered cognitive behavioral therapy program for irritable bowel syndrome. Neurogastroenterology & Motility 33:11.
Crossref
Crossref
Iris Rijnaarts, Ben J.M. Witteman, Erwin G. Zoetendal, Coen Govers, Nicole J.W. de Wit & Nicole M. de Roos. (2021) Subtypes and Severity of Irritable Bowel Syndrome Are Not Related to Patients’ Self-Reported Dietary Triggers: Results From an Online Survey in Dutch Adults. Journal of the Academy of Nutrition and Dietetics 121:9, pages 1750-1762.e8.
Crossref
Crossref
Magdy El-Salhy, Christina Casen, Jørgen Valeur, Trygve Hausken & Jan Gunnar Hatlebakk. (2021) Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World Journal of Gastroenterology 27:18, pages 2219-2237.
Crossref
Crossref
Ahmad Ozair, Rahul Kumar, Balendra P Singh, Uday Chand Ghoshal, Vivek Bhat & Richard Kirubakaran. (2021) Antibiotics for treatment of irritable bowel syndrome in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Magdy El‐Salhy, Jørgen Valeur, Trygve Hausken & Jan Gunnar Hatlebakk. (2020) Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. Neurogastroenterology & Motility 33:2.
Crossref
Crossref
Ami D. Sperber, Shrikant I. Bangdiwala, Douglas A. Drossman, Uday C. Ghoshal, Magnus Simren, Jan Tack, William E. Whitehead, Dan L. Dumitrascu, Xuicai Fang, Shin Fukudo, John Kellow, Edith Okeke, Eamonn M.M. Quigley, Max Schmulson, Peter Whorwell, Timothy Archampong, Payman Adibi, Viola Andresen, Marc A. Benninga, Bruno Bonaz, Serhat Bor, Luis Bustos Fernandez, Suck Chei Choi, Enrico S. Corazziari, Carlos Francisconi, Albis Hani, Leonid Lazebnik, Yeong Yeh Lee, Agata Mulak, M. Masudur Rahman, Javier Santos, Mashiko Setshedi, Ari Fahrial Syam, Stephen Vanner, Reuben K. Wong, Aurelio Lopez-Colombo, Valeria Costa, Ram Dickman, Motoyori Kanazawa, Ammar Hassanzadeh Keshteli, Rutaba Khatun, Iradj Maleki, Pierre Poitras, Nitesh Pratap, Oksana Stefanyuk, Sandie Thomson, Judith Zeevenhooven & Olafur S. Palsson. (2021) Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 160:1, pages 99-114.e3.
Crossref
Crossref
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Anja Bråthen Kristoffersen & Trygve Hausken. (2020) Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 69:5, pages 859-867.
Crossref
Crossref
Gillian E. Cassar, George J. Youssef, Simon Knowles, Richard Moulding & David W. Austin. (2020) Health-Related Quality of Life in Irritable Bowel Syndrome. Gastroenterology Nursing 43:3, pages E102-E122.
Crossref
Crossref
Mohammad A. Baram, Amir Abbasnezhad, Koroush Ghanadi, Khatereh Anbari, Razieh Choghakhori & Hassan Ahmadvand. (2020) Serum Levels of Chemerin, Apelin, and Adiponectin in Relation to Clinical Symptoms, Quality of Life, and Psychological Factors in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 54:5, pages e40-e49.
Crossref
Crossref
Patimah Abdul Wahab, Dariah Mohd Yusoff, Azidah Abdul Kadir, Siti Hawa Ali, Yeong Yeh Lee & Yee Cheng Kueh. (2020) Psychometric evaluation of a newly developed Elderly-Constipation Impact Scale. PeerJ 8, pages e8581.
Crossref
Crossref
Mana H. Vriesman, Shaman Rajindrajith, Ilan J.N. Koppen, Faridi S. van Etten- Jamaludin, Marieke van Dijk, Niranga M. Devanarayana, Merit M. Tabbers & Marc A. Benninga. (2019) Quality of Life in Children with Functional Constipation: A Systematic Review and Meta-Analysis. The Journal of Pediatrics 214, pages 141-150.
Crossref
Crossref
Danilo Paduano, Arianna Cingolani, Elisabetta Tanda & Paolo Usai. (2019) Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life. Nutrients 11:7, pages 1566.
Crossref
Crossref
Magdy El-Salhy, Trygve Hausken & Jan Gunnar Hatlebakk. (2019) Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients 11:6, pages 1415.
Crossref
Crossref
Amir Abbasnezhad & Razieh Choghakhori. 2019. Dietary Interventions in Gastrointestinal Diseases. Dietary Interventions in Gastrointestinal Diseases
81
88
.
Mohammad Javad Zahedi, Vahideh Behrouz & Maryam Azimi. (2018)
Low fermentable oligo‐di‐mono‐saccharides and polyols diet
versus
general dietary advice in patients with diarrhea‐predominant irritable bowel syndrome: A randomized controlled trial
. Journal of Gastroenterology and Hepatology 33:6, pages 1192-1199.
Crossref
Crossref
Ismael De Jesús Yepes, María Nicol Múnera & Carlos Martelo. (2017) Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia. Biomédica 38, pages 61-68.
Crossref
Crossref
Shaman Rajindrajith, Niranga M. Devanarayana & Marc A. Benninga. (2017) Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria. Journal of Pediatric Gastroenterology & Nutrition 64:5, pages 679-684.
Crossref
Crossref
Sanda Pletikosić Tončić & Mladenka Tkalčić. (2017) A Measure of Suffering in relation to Anxiety and Quality of Life in IBS Patients: Preliminary Results. BioMed Research International 2017, pages 1-7.
Crossref
Crossref
Jiyeon Lee, Eun-Hyun Lee & Seung Hei Moon. (2016) A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome. Quality of Life Research 25:12, pages 2985-2995.
Crossref
Crossref
Shahrzad Ghiyasvandian, Mojtaba Ghorbani, Masoumeh Zakerimoghadam, Zahra Purfarzad & Anoshirvan Kazemnejad. (2016) The Effects of a Self-Care Program on the Severity of Symptoms and Quality of Life of Patients With Irritable Bowel Syndrome. Gastroenterology Nursing 39:5, pages 359-365.
Crossref
Crossref
Andrew Ming Liang & Yu Tien. (2016) Quality of Life in Irritable Bowel Syndrome: A Narrative Overview. Journal of Archives in Military Medicine 4:1.
Crossref
Crossref
Véronique De Gucht. (2015) Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients. Quality of Life Research 24:8, pages 1845-1856.
Crossref
Crossref
Chad K. Porter, Nadia Thura, Carey D. Schlett, John W. Sanders, David R. Tribble, Marshall R. Monteville & Mark S. Riddle. (2015) Establishment of Health Utility Indices for Post-Infectious Functional Gastrointestinal Disorders in Active Duty Us Military. Journal of Travel Medicine 22:4, pages 237-241.
Crossref
Crossref
Prashant Singh. (2015) Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World Journal of Gastroenterology 21:26, pages 8103.
Crossref
Crossref
Jeffrey M Lackner, Gregory D Gudleski, Chang-Xing Ma, Akriti Dewanwala & Bruce Naliboff. (2014) Fear of GI Symptoms has an Important Impact on Quality of Life in Patients With Moderate-to-Severe IBS. American Journal of Gastroenterology 109:11, pages 1815-1823.
Crossref
Crossref
Shaman Rajindrajith, Niranga Manjuri Devanarayana, Lasanthi Weerasooriya, Wathsala Hathagoda & Marc A. Benninga. (2013) Quality of Life and Somatic Symptoms in Children with Constipation: A School-Based Study. The Journal of Pediatrics 163:4, pages 1069-1072.e1.
Crossref
Crossref
Yungwui Tjong, Siupo Ip, Lixing Lao, Harry H.S. Fong, Joseph J.Y. Sung, Brian Berman & Chuntao Che. (2011) Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome. Journal of Ethnopharmacology 135:3, pages 754-761.
Crossref
Crossref